# 510(k) Summary

Introduction: According to the requirements of 21 CFR 807.92, the following information provides sufficient details to understand the basis for determination of substantial equivalence.

The assigned 510(k) Number : K132801

Date Prepared:

May 23rd, 2014

2 Submitter Mailing Address:

Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue   
Tarrytown, NY 10591

# Contact Person:

Ernest Joseph   
Senior Manager, Regulatory Affairs   
(914)-524-2431   
(914)-524-2101   
ernest.joseph@siemens.com

Phone Number: Fax Number: E-mail Address:

3.Device Name Proprietary Name: Device Common Name: Regulation Number: Classification: Classification Products Code: Panel:

IMMULITE® 2000 3gAllergyT Specific IgE Universal Kit   
Radioallergosorbent (RAST) Immunological Test System   
866.5750   
Class II   
DHB   
Immunology (82)

4. Predicate Device Name

IMMULITE® 2000 3gAllergy™M Specific IgE Assay

FDA clearance was previously obtained for the assay kit and 111 specific allergens (K093987, K100910, K101572 and K112523).

5. Device Description:

IMMULITE $\mathfrak { Q }$ 2000 3gAllergy™ Specific IgE Universal Kit assay is a solid-phase, two-step, chemiluminescent immunoassay that exploits liquid phase kinetics in a bead format. It represents a significant advance over conventional methods relying on allergens attached to a solid-phase support. The allergens are covalently bound to a soluble polymer/co-polymer matrix, which in turn is labeled with a ligand. The use of an amino acid co-polymer amplifies the amount of allergen that the matrix can support. This 510(k) submission is for clearance of seven additional specific molecular allergens shown in Table 1 to be used with the IMMULITE $\mathfrak { P }$ 2000 3gAllergy™M Specific IgE Universal Kit on the IMMULITE $\otimes$ 2000 analyzer.

# Table 1: Specific Molecular Allergens

1 rBet v 2: Birch pollen (Betula verrucosa)   
2 rMal d 1: Apple (Malus domestica)   
3 rPru av 1: Cherry (Prunus avium)   
4 rPru av3: Cherry (Prunus avium)   
5 rPru av 4: Cherry (Prunus avium)   
6 nPru p 3: Peach (Prunus persica)   
7 rMal d 4: Apple (Malus domestica)

Intended Use: Indication for Use:

See Indications for Use Statement below   
The IMMULITE® 2000 3gAllergyTM Specific IgE Universal Kit is for in vitro diagnostic use with the IMMULITE $\otimes$ 2000 Analyzer — for the quantitative measurement of allergenspecific IgE in human serum, as an aid in the clinical diagnosis of IgE-mediated allergic disorders. The test results are to be used in conjunction with clinical findings and other laboratory tests.

# Special Conditions for

Use Statement(s): Special Instrument Requirements:

For prescription use only

# IMMULITE® 2000 Systems

7. Technological Characteristics and Substantial Equivalence Comparison with Predicate:

A comparison of the device features, intended use, and other information demonstrates that the IMMULITE 2000 3gAllergyTM Specific IgE Universal Kit is substantially equivalent to the predicate device summarized in Table 2.

Table 2: Substantial Equivalence Comparison   

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Description Item</td><td colspan="1" rowspan="1">Candidate Device :IMMULITE® 2000 3gAllergyTMSpecific IgE Universal Kit</td><td colspan="1" rowspan="1">Predicate Device:(k112523)</td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">The IMMULITE® 2000 3gAllergyT Specific IgE UniversalKit is for in vitro diagnostic use with the IMMULITE® 2000Analyzer— for the quantitative measurement of allergen-specific IgE in human serum, as an aid in the clinicaldiagnosis of IgE-mediated allergic disorders. The test resultsare to be used in conjunction with clinical findings and otherlaboratory tests.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Number ofCalibrators</td><td colspan="1" rowspan="1">Eight</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample Matrix</td><td colspan="1" rowspan="1">Serum</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Antibody</td><td colspan="1" rowspan="1">Monoclonal murine anti-human IgE conjugated toalkaline phosphatase</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Basic Principle</td><td colspan="1" rowspan="1">Chemiluminescent Immunoassay</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample Volume</td><td colspan="1" rowspan="1">50 μl</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Process Time</td><td colspan="1" rowspan="1">65 minutes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">IncubationTemperature</td><td colspan="1" rowspan="1">37°C</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Description Item</td><td colspan="1" rowspan="1">Candidate Device :IMMULITE® 2000 3gAllergyTMSpecific IgE Universal Kit</td><td colspan="1" rowspan="1">Predicate Device:(k112523)</td></tr><tr><td colspan="1" rowspan="1">AllergenSource</td><td colspan="1" rowspan="1">Allergenic proteins expressed byrecombinant techniques or purified fromnative sources.</td><td colspan="1" rowspan="1">Whole allergenextracts or Allergenicproteins purifiedfrom native sourcesonly.</td></tr></table>

# 8. Non-Clinical Performance Testing

Performance testing has been carried out to demonstrate that this device meets the performance specifications for its intend use. The following tests were performed on the candidate device.

# 8.1 Precision

Precision studies were performed in accordance with Clinical Laboratory Standard Institute (CLSI) guidance: Evaluation of Precision Performance of Quantitative Methods; Approved GuidelineSecond Edition. CLSI document EP5-A2 (ISBN 1-56238-542-9). CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2004 assaying each test sample in two runs per day on 20 different days. Analysis of variance was used to estimate the repeatability and within-lab precision.

Four allergen lots were tested using three positive samples and one negative control sample. Repeatability, within-lab, and lot-to-lot precision for the positive samples were evaluated by calculating the kU/L dose percent coefficients of variation $( \% C V )$ for each positive sample. Nonspecific binding (NSB) was monitored by testing the negative control sample. Precision outliers according to the ${ > } 3 . 0$ SD rule are attributed to sample specific issues and/or operator error. In these cases precision results will be included with and without outliers. Representative precision claims for each allergen tested are presented in Table 3.

Precision studies were conducted using instruments [3325 and 13474 for lots 110, 111, and 112 and instruments I3325 and I3476 for lot 201. Data for each lot on each instrument is presented below:

Table 3 - Repeatability and Within-Lab Precision Results   

<table><tr><td colspan="4">Repeatability</td><td colspan="2">Within-Lab</td></tr><tr><td>Sample</td><td>N</td><td>Mean</td><td>SD</td><td>CV</td><td>SD</td><td>CV</td></tr><tr><td></td><td></td><td>(KU/L) Allergen = rBet v 2, Lot 110, I3325</td><td>(KU/L)</td><td>%</td><td>(kU/L)</td><td>%</td></tr><tr><td colspan="5">Positive 1</td><td>0.043</td><td>7.17</td></tr><tr><td>Positive 2</td><td>84 84</td><td>0.60 1.62</td><td>0.020 0.053</td><td>3.40 3.30</td><td>0.096</td><td>5.91</td></tr><tr><td></td><td></td><td>8.16</td><td>0.293</td><td>3.59</td><td>0.598</td><td>7.33</td></tr><tr><td>Positive 3</td><td>84</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="7">Allergen = rBet v 2, Lot 110, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.63</td><td>0.026</td><td>4.13</td><td>0.036</td><td>5.66</td></tr><tr><td>Positive 2</td><td>84</td><td>1.70</td><td>0.057</td><td>3.33</td><td>0.097</td><td>5.69</td></tr><tr><td>Positive 3</td><td>84</td><td>8.41</td><td>0.334</td><td>3.98</td><td>0.440</td><td>5.23</td></tr><tr><td colspan="7">Allergen = rBet v 2, Lot 111, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.60</td><td>0.021</td><td>3.51</td><td>0.037</td><td>6.15</td></tr><tr><td>Positive 2</td><td>84</td><td>1.62</td><td>0.057</td><td>3.52</td><td>0.102</td><td>6.31</td></tr><tr><td>Positive 3</td><td>84</td><td>8.20</td><td>0.280</td><td>3.42</td><td>0.577</td><td>7.04</td></tr><tr><td colspan="7">Allergen = rBet v 2. Lot 111, I13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.64</td><td>0.032</td><td>4.97</td><td>0.041</td><td>6.36</td></tr><tr><td>Positive 2</td><td>84</td><td>1.71</td><td>0.052</td><td>3.03</td><td>0.089</td><td>5.21</td></tr><tr><td>Positive 3</td><td>84</td><td>8.44</td><td>0.316</td><td>3.74</td><td>0.396</td><td>4.69</td></tr><tr><td colspan="7">Allergen = rBet v 2, Lot 112, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.60</td><td>0.019</td><td>3.09</td><td>0.038</td><td>6.43</td></tr><tr><td>Positive 2</td><td>84</td><td>1.62</td><td>0.058</td><td>3.57</td><td>0.104</td><td>6.44</td></tr><tr><td>Positive 3</td><td>84</td><td>8.30</td><td>0.247</td><td>2.97</td><td>0.603</td><td>7.26</td></tr><tr><td colspan="7">Allergen = rBet v 2, Lot 112, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.63</td><td>0.032</td><td>5.07</td><td>0.046</td><td>7.32</td></tr><tr><td>Positive 2</td><td>84</td><td>1.71</td><td>0.065</td><td>3.80</td><td>0.102</td><td>5.97</td></tr><tr><td>Positive 3</td><td>84</td><td>8.46</td><td>0.299</td><td>3.54</td><td>0.462</td><td>5.46</td></tr><tr><td colspan="7">Allergen = rBet v 2, Lot 201, 13325</td></tr><tr><td>Positive 1</td><td>80</td><td>0.46</td><td>0.016</td><td>3.49</td><td>0.022</td><td>4.63</td></tr><tr><td>Positive 2</td><td>80</td><td>1.34</td><td>0.046</td><td>3.41</td><td>0.058</td><td>4.36</td></tr><tr><td>Positive 3</td><td>80</td><td>6.68</td><td>0.220</td><td>3.30</td><td>0.278</td><td>4.16</td></tr><tr><td colspan="7">Allergen = rBet v 2, Lot 201, I3476</td></tr><tr><td>Positive 1</td><td>80</td><td>0.49</td><td>0.019</td><td>3.89</td><td>0.035</td><td>7.17</td></tr><tr><td>Positive 2</td><td>80</td><td>1.43</td><td>0.047</td><td>3.30</td><td>0.075</td><td>5.20</td></tr><tr><td>Positive 3</td><td>80</td><td>7.18</td><td>0.243</td><td>3.39</td><td>0.413</td><td>5.75</td></tr><tr><td colspan="7"></td></tr><tr><td>Allergen = rMal d 1, Lot 110, I13325</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1 Positive 2</td><td>84</td><td>0.57</td><td>0.026</td><td>4.58</td><td>0.042</td><td>7.27 7.18</td></tr><tr><td>Positive 3</td><td>84</td><td>2.78</td><td>0.115</td><td>4.14</td><td>0.200</td><td></td></tr><tr><td></td><td>84</td><td>5.64</td><td>0.236</td><td>4.18</td><td>0.418</td><td>7.41</td></tr><tr><td colspan="7">Allergen = rMal d 1, Lot 110, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.60</td><td>0.027</td><td>4.60</td><td>0.044</td><td>7.45</td></tr><tr><td>Positive 2</td><td>84</td><td>2.97</td><td>0.158</td><td>5.32</td><td>0.206</td><td>6.92</td></tr><tr><td>Positive 3</td><td>84</td><td>5.85</td><td>0.221</td><td>3.78</td><td>0.286</td><td>4.89</td></tr><tr><td colspan="7">Allergen = rMal d 1, Lot 111, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.58</td><td>0.027</td><td>4.68</td><td>0.044</td><td>7.60</td></tr><tr><td>Positive 2</td><td>84</td><td>2.79</td><td>0.114</td><td>4.08</td><td>0.204</td><td>7.32</td></tr><tr><td>Positive 3</td><td>84</td><td>5.63</td><td>0.226</td><td>4.01</td><td>0.391</td><td>6.95</td></tr><tr><td rowspan="2"></td><td colspan="5">Allergen = rMal d 1, Lot 111, 13474</td><td rowspan="2"></td></tr><tr><td></td><td>0.60</td><td>0.024</td><td>4.03</td><td>0.041</td></tr><tr><td>Positive 1</td><td>84</td><td></td><td>0.112</td><td>3.79</td><td>0.172</td><td>6.87 5.84</td></tr><tr><td>Positive 2</td><td>84 84</td><td>2.94</td><td>0.267</td><td>4.52</td><td>0.286</td><td>4.85</td></tr><tr><td>Positive 3</td><td></td><td>5.90</td><td>Allergen = rMal d 1, Lot 112, I3325</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>0.028</td><td>4.50</td><td>0.044</td><td>7.10</td></tr><tr><td>Positive 1 Positive 2</td><td>84</td><td>0.62</td><td></td><td></td><td>0.177</td><td></td></tr><tr><td>Positive 3</td><td>84 84</td><td>2.45</td><td>0.096</td><td>3.90</td><td></td><td>7.20</td></tr><tr><td></td><td></td><td>5.96</td><td>0.227</td><td>3.80</td><td>0.438</td><td>7.30</td></tr><tr><td></td><td></td><td></td><td>Allergen = rMal d 1, Lot 112, I3474</td><td></td><td></td><td></td></tr><tr><td>Positive 1 Positive 2</td><td>84</td><td>0.64</td><td>0.031</td><td>4.90</td><td>0.054</td><td>8.50</td></tr><tr><td>Positive 3</td><td>84 84</td><td>2.59 6.06</td><td>0.106 0.284</td><td>4.10</td><td>0.201</td><td>7.80</td></tr><tr><td></td><td></td><td></td><td>Allergen = rMal d 1, Lot 201, 13325</td><td>4.70</td><td>0.396</td><td>6.50</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1</td><td>80</td><td>0.46</td><td>0.023</td><td>4.93</td><td>0.035</td><td>7.53</td></tr><tr><td>Positive 2 Positive 3</td><td>80</td><td>1.97</td><td>0.068</td><td>3.44</td><td>0.085</td><td>4.29</td></tr><tr><td></td><td>80</td><td>4.52</td><td>0.189</td><td>4.18</td><td>0.423</td><td>9.36</td></tr><tr><td></td><td></td><td></td><td></td><td>Allergen = rMal d 1, Lot 201, 13476</td><td></td><td></td></tr><tr><td>Positive 1 Positive 2</td><td>80</td><td>0.49</td><td>0.021</td><td>4.24</td><td>0.035</td><td>7.26</td></tr><tr><td>Positive 3</td><td>80</td><td>2.16</td><td>0.101</td><td>4.69</td><td>0.189</td><td>8.76</td></tr><tr><td></td><td>80</td><td>4.99</td><td>0.209</td><td>4.19</td><td>0.371</td><td>7.43</td></tr><tr><td></td><td></td><td></td><td></td><td>Allergen = rMal d 4, Lot 110, 13325</td><td></td><td></td></tr><tr><td>Positive 1 Positive 2</td><td>84</td><td>0.64</td><td>0.027</td><td>4.18</td><td>0.036</td><td>5.60</td></tr><tr><td>Positive 3</td><td>84</td><td>1.67</td><td>0.063</td><td>3.78</td><td>0.105</td><td>6.29</td></tr><tr><td></td><td>84</td><td>7.37</td><td>0.206</td><td>2.79</td><td>0.469</td><td>6.36</td></tr><tr><td>Allergen = rMal d 4, Lot 110, 13474</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1 Positive 2</td><td>84</td><td>0.67</td><td>0.021</td><td>3.14</td><td>0.038</td><td>5.64</td></tr><tr><td>Positive 3</td><td>84</td><td>1.73</td><td>0.052.</td><td>3.02</td><td>0.108</td><td>6.21</td></tr><tr><td></td><td>84</td><td>7.70</td><td>0.291</td><td>3.77</td><td>0.323</td><td>4.19</td></tr><tr><td></td><td></td><td>Allergen = rMal d 4, Lot 111, I3325</td><td></td><td></td><td>0.037</td><td>5.84</td></tr><tr><td>Positive 1 Positive 2</td><td>84 84</td><td>0.63</td><td>0.027 0.055</td><td>4.31 3.29</td><td>0.103</td><td>6.23</td></tr><tr><td>Positive 3</td><td></td><td>1.66</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>84</td><td>7.40</td><td>0.255</td><td>3.44</td><td>0.500</td><td>6.75</td></tr><tr><td></td><td></td><td></td><td></td><td>Allergen = rMal d 4, Lot 111, I3474</td><td></td><td>5.35</td></tr><tr><td>Positive 1 Positive 2</td><td>84 84</td><td>0.67 1.74</td><td>0.025 0.049</td><td>3.73 2.84</td><td>0.036 0.102</td><td>5.90</td></tr><tr><td></td><td></td><td></td><td>0.217</td><td></td><td></td><td></td></tr><tr><td>Positive 3</td><td>84</td><td>7.71</td><td></td><td>2.82</td><td>0.350</td><td>4.54</td></tr></table>

<table><tr><td colspan="6">Allergen = rMal d 4, Lot 112, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.65</td><td>0.028</td><td>4.25</td><td>0.038 5.76</td></tr><tr><td>Positive 2</td><td>84</td><td>1.66</td><td>0.060</td><td>3.58</td><td>0.105 6.29</td></tr><tr><td>Positive 3</td><td>84</td><td>7.56</td><td>0.265 3.51</td><td>0.533</td><td>7.06</td></tr><tr><td colspan="6"></td></tr><tr><td colspan="6">Allergen = rMal d 4, Lot 112, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.69 0.022</td><td>3.13</td><td>0.041</td><td>5.88</td></tr><tr><td>Positive 2</td><td>84</td><td>1.75</td><td>0.056 3.23 →</td><td>0.090</td><td>5.16</td></tr><tr><td>Positive 3</td><td>84</td><td>7.90 0.264</td><td>3.35</td><td>0.377</td><td>4.78</td></tr><tr><td colspan="6">Allergen = rMal d 4, Lot 201, 13325</td></tr><tr><td>Positive 1</td><td></td><td>0.59</td><td>0.022</td><td></td><td></td></tr><tr><td>Positive 2</td><td>80 80</td><td>1.43</td><td>3.74 0.053 3.73</td><td>0.028 0.060</td><td>4.70</td></tr><tr><td>Positive 3</td><td>80</td><td>6.61</td><td>0.218 3.30</td><td>0.268</td><td>4.24 4.06</td></tr><tr><td colspan="6">Allergen = rMal d 4, Lot 201, I3476</td></tr><tr><td>Positive 1</td><td>80</td><td>0.64 0.021</td><td>3.24</td><td>0.036</td><td></td></tr><tr><td>Positive 2</td><td>80</td><td>1.52</td><td>0.045 2.93</td><td>0.077</td><td>5.56</td></tr><tr><td>Positive 3</td><td>80</td><td>7.21</td><td>0.119 1.65</td><td>0.330</td><td>5.08 4.58</td></tr><tr><td colspan="6"></td></tr><tr><td></td><td>Allergen = rPru av 1, Lot 110, I3325</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="6"></td></tr><tr><td>Positive 1 Positive 2*</td><td>84</td><td>0.58 0.024</td><td>4.13</td><td>0.037</td><td>6.48</td></tr><tr><td>Positive 2**</td><td>84</td><td>2.34 2.41</td><td>0.083 3.53 3.49</td><td>0.337</td><td>14.36</td></tr><tr><td>Positive 3</td><td>80 84</td><td>6.22</td><td>0.084</td><td>0.165</td><td>6.84</td></tr><tr><td></td><td></td><td>0.267</td><td>4.29</td><td>0.432</td><td>6.94</td></tr><tr><td colspan="6">Allergen = rPru av 1, Lot 110, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.60</td><td>0.024</td><td>4.01</td><td>0.044 7.22</td></tr><tr><td>Positive 2</td><td>84</td><td>2.50</td><td>0.088 3.50</td><td>0.142</td><td>5.67</td></tr><tr><td>Positive 3</td><td>84</td><td>6.39</td><td>0.232 3.63</td><td>0.428</td><td>6.70</td></tr><tr><td colspan="6">Allergen = rPru av 1, Lot 111, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.58</td><td>0.022</td><td>3.76</td><td>0.042 7.21</td></tr><tr><td>Positive 2*</td><td>84</td><td>2.35</td><td>0.058 2.46</td><td>0.338</td><td>14.38</td></tr><tr><td>Positive 2**</td><td>80</td><td>2.41</td><td>0.059 2.43</td><td>0.179</td><td>7.41</td></tr><tr><td>Positive 3</td><td>84</td><td>6.29</td><td>0.197 3.14</td><td>0.454</td><td>7.22</td></tr><tr><td colspan="6">Allergen = rPru av 1, Lot 111, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.60</td><td>0.022</td><td>3.70</td><td>0.041 6.74</td></tr><tr><td>Positive 2</td><td>84</td><td>2.49</td><td>0.103</td><td>4.16 0.156</td><td>6.28</td></tr><tr><td>Positive 3</td><td>84</td><td>6.50</td><td>0.275 4.23</td><td>0.394</td><td>6.06</td></tr><tr><td colspan="6">Allergen = rPru av 1, Lot 112, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.65</td><td>0.024</td><td>3.70 0.047</td><td>7.26</td></tr><tr><td>Positive 2*</td><td>84</td><td>2.57</td><td>0.096 3.74</td><td>0.359</td><td>13.96</td></tr><tr><td>Positive 2**</td><td>80</td><td>2.64</td><td>0.098 3.73</td><td>0.186</td><td>7.06</td></tr><tr><td>Positive 3</td><td>84</td><td>7.91</td><td>0.257 3.24</td><td>0.552</td><td>6.98</td></tr><tr><td colspan="6">av 1, Lot 112, I3474</td></tr><tr><td>Positive 1</td><td>84</td><td>Allergen = rPru 0.69</td><td>0.025 3.66</td><td>0.044</td><td>6.42</td></tr><tr><td>Positive 2</td><td>84</td><td>2.78</td><td>0.095</td><td>3.43 0.179</td><td>6.45</td></tr><tr><td>Positive 3</td><td>84</td><td>8.29</td><td>0.365</td><td>4.40 0.535</td><td>6.45</td></tr><tr><td colspan="6">Allergen = rPru av 1, Lot 201, 13325</td></tr><tr><td>Positive 1</td><td>80</td><td>0.56</td><td>0.020 3.62</td><td>0.039</td><td>6.94</td></tr><tr><td>Positive 2</td><td>80</td><td>2.29</td><td>0.076 3.34</td><td>0.130</td><td>5.66</td></tr><tr><td>Positive 3</td><td>80</td><td>6.83</td><td>0.207</td><td>3.03 0.307</td><td>4.49</td></tr><tr><td colspan="6">Allergen = rPru av 1, Lot 201, 13476</td></tr><tr><td>Positive 1*</td><td>80</td><td>0.60</td><td>0.066</td><td>11.16 0.074</td><td>12.41</td></tr><tr><td>Positive 1**</td><td>79</td><td>0.60</td><td>0.017 2.86</td><td>0.044</td><td>7.33</td></tr><tr><td>Positive 2</td><td>80</td><td>2.48</td><td>0.128</td><td>5.17 0.211</td><td>8.51</td></tr><tr><td>Positive 3</td><td>80</td><td>7.37</td><td>0.375</td><td>5.09 0.662</td><td>8.98</td></tr></table>

\*Outliers detected on Day 6, Runs 1 and 2, Replicates 1 and 2 \*Outliers detected on Day 20, Run 1, Replicate 2 \*\*No outliers used in calculation

<table><tr><td colspan="6">Allergen = rPru av 3, Lot 110, I3325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.56</td><td>0.020</td><td>3.51</td><td>0.032 5.81</td></tr><tr><td>Positive 2</td><td>84</td><td>1.48</td><td>0.044</td><td>2.97</td><td>0.090 6.04</td></tr><tr><td>Positive 3</td><td>84</td><td>9.30</td><td>0.398</td><td>4.28</td><td>0.697 7.49</td></tr><tr><td colspan="6">Allergen = rPru av 3, Lot 110, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.59</td><td>0.022</td><td>3.63</td><td>0.034 5.76</td></tr><tr><td>Positive 2</td><td>84</td><td>1.55</td><td>0.050</td><td>3.22</td><td>0.079 5.08</td></tr><tr><td>Positive 3</td><td>84</td><td>9.60</td><td>0.371</td><td>3.86</td><td>0.486 5.06</td></tr><tr><td colspan="6">Allergen = rPru av 3, Lot 111, I3325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.56</td><td>0.021</td><td>3.74 0.036</td><td>6.42</td></tr><tr><td>Positive 2</td><td>84</td><td>1.49</td><td>0.055</td><td>3.68</td><td>0.092 6.19</td></tr><tr><td>Positive 3</td><td>84</td><td>9.28</td><td>0.366</td><td>3.94</td><td>0.598 6.45</td></tr><tr><td colspan="6"></td></tr><tr><td>Positive 1</td><td>84</td><td>0.59</td><td>Allergen = rPru av 3, Lot 111, 13474 0.020</td><td>3.34</td><td>0.034 5.74</td></tr><tr><td>Positive 2</td><td>84</td><td>1.56</td><td>0.050</td><td>3.21</td><td></td></tr><tr><td>Positive 3</td><td>84</td><td>9.66</td><td>0.331</td><td>3.43</td><td>0.079 5.03 0.509 5.27</td></tr></table>

<table><tr><td colspan="7">Allergen = rPru av 3, Lot 112, I3325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.56</td><td>0.024</td><td>4.25</td><td>0.032</td><td>5.60</td></tr><tr><td>Positive 2</td><td>84</td><td>1.47</td><td>0.041</td><td>2.82</td><td>0.086</td><td>5.85</td></tr><tr><td>Positive 3</td><td>84</td><td>9.49</td><td>0.290</td><td>3.05</td><td>0.645</td><td>6.80</td></tr><tr><td colspan="7">Allergen = rPru av 3, Lot 112, I13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.59</td><td>0.021</td><td>3.62</td><td>0.034</td><td>5.66</td></tr><tr><td>Positive 2</td><td>84</td><td>1.55</td><td>0.058</td><td>3.74</td><td>0.075</td><td>4.84</td></tr><tr><td>Positive 3</td><td>84</td><td>9.89</td><td>0.300</td><td>3.03</td><td>0.485</td><td>4.90</td></tr><tr><td colspan="7">Allergen = rPru av 3, Lot 201, 13325</td></tr><tr><td>Positive 1*</td><td>80</td><td>0.48</td><td>0.058</td><td>12.20</td><td>0.061</td><td>12.85</td></tr><tr><td>Positive 1**</td><td>79</td><td>0.48</td><td>0.025</td><td>5.17</td><td>0.035</td><td>7.23</td></tr><tr><td>Positive 2</td><td>80</td><td>1.20</td><td>0.53</td><td>4.40</td><td>0.96</td><td>8.01</td></tr><tr><td>Positive 3</td><td>80</td><td>7.52</td><td>0.236</td><td>3.14</td><td>0.468</td><td>6.23</td></tr><tr><td colspan="7">Allergen = rPru av 3, Lot 201, 13476</td></tr><tr><td>Positive 1</td><td>80</td><td>0.51</td><td>0.015</td><td>2.88</td><td>0.035</td><td></td></tr><tr><td>Positive 2</td><td>80</td><td>1.30</td><td>0.047</td><td>3.60</td><td>0.097</td><td>6.73 7.51</td></tr><tr><td>Positive 3</td><td>80</td><td>8.25</td><td>0.213</td><td>2.58</td><td>0.484</td><td>5.86</td></tr><tr><td colspan="7">*Outliers detected on Day 16, Run 1, Replicate 1</td></tr><tr><td colspan="7">**No outliers used for calculation</td></tr><tr><td colspan="7">Allergen = rPru av 4, Lot 110, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.62</td><td>0.026</td><td>4.13</td><td>0.035</td><td>5.68</td></tr><tr><td>Positive 2*</td><td>84</td><td>1.27</td><td>0.048</td><td>3.78</td><td>0.223</td><td>17.58</td></tr><tr><td>Positive 2**</td><td>82</td><td>1.30</td><td>0.049</td><td>3.73</td><td>0.098</td><td>7.56</td></tr><tr><td>Positive 3</td><td>84</td><td>8.75</td><td>0.297</td><td>3.40</td><td>0.644</td><td>7.36</td></tr><tr><td colspan="7">Allergen = rPru av 4, Lot 110, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.66</td><td>0.028</td><td>4.23</td><td>0.043</td><td>6.47</td></tr><tr><td>Positive 2</td><td>84</td><td>1.36</td><td>0.043</td><td>3.14</td><td>0.080</td><td>5.89</td></tr><tr><td>Positive 3</td><td>84</td><td>9.09</td><td>0.309</td><td>3.40</td><td>0.409</td><td>4.50</td></tr><tr><td colspan="7">Allergen = rPru av 4, Lot 111, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.62</td><td>0.022</td><td>3.61</td><td>0.035</td><td>5.56</td></tr><tr><td>Positive 2*</td><td>84</td><td>1.27</td><td>0.042</td><td>3.33</td><td>0.221</td><td>17.35</td></tr><tr><td>Positive 2**</td><td>82</td><td>1.30</td><td>0.043</td><td>3.29</td><td>0.092</td><td>7.08</td></tr><tr><td>Positive 3</td><td>84</td><td>8.63</td><td>0.349</td><td>4.04</td><td>0.692</td><td>8.02</td></tr><tr><td colspan="7">Allergen = rPru av 4, Lot 111, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.66</td><td>0.028</td><td>4.20</td><td>0.044</td><td>6.57</td></tr><tr><td>Positive 2</td><td>84</td><td>1.37</td><td>0.041</td><td>2.96</td><td>0.070</td><td>5.07</td></tr><tr><td>Positive 3</td><td>84</td><td>9.06</td><td>0.408</td><td>4.50</td><td>0.505</td><td>5.57</td></tr></table>

<table><tr><td colspan="8"></td></tr><tr><td></td><td></td><td></td><td>Allergen = rPru av 4, Lot 112, I3325</td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1</td><td>84</td><td>0.62</td><td>0.022</td><td></td><td>3.59</td><td>0.040</td><td>6.51</td></tr><tr><td>Positive 2*</td><td>84</td><td>1.29</td><td>0.042</td><td></td><td>3.29</td><td>0.222</td><td>17.21</td></tr><tr><td>Positive 2**</td><td>82</td><td>1.30</td><td>0.043</td><td></td><td>3.29</td><td>0.092</td><td>7.08</td></tr><tr><td>Positive 3</td><td>84</td><td>8.63</td><td>0.410</td><td></td><td>4.73</td><td>0.647</td><td>7.45</td></tr><tr><td></td><td></td><td>Allergen = rPru av 4, Lot 112, 13474</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1</td><td>84</td><td>0.67</td><td></td><td>0.021</td><td>3.16</td><td>0.033</td><td>4.95</td></tr><tr><td>Positive 2</td><td>84</td><td>1.39</td><td></td><td>0.048</td><td>3.46</td><td>0.087</td><td>6.21</td></tr><tr><td>Positive 3</td><td>84</td><td>6.17</td><td>0.388</td><td></td><td>4.23</td><td>0.601</td><td>6.55</td></tr><tr><td>Allergen = rPru av 4, Lot 201, 13325</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1</td><td>80</td><td>0.63</td><td>0.018</td><td></td><td>2.94</td><td>0.035</td><td>5.54</td></tr><tr><td>Positive 2</td><td>82</td><td>1.19</td><td></td><td>0.029</td><td>2.45</td><td>0.056</td><td>4.72</td></tr><tr><td>Positive 3</td><td>80</td><td>7.18</td><td></td><td>0.258</td><td>3.58</td><td>0.554</td><td>7.71</td></tr><tr><td colspan="8">Allergen = rPru av 4, Lot 201, 13476</td></tr><tr><td>Positive 1</td><td>80</td><td>0.68</td><td>0.019</td><td></td><td>2.81</td><td>0.040</td><td>5.92</td></tr><tr><td>Positive 2</td><td>80</td><td>1.25</td><td></td><td>0.038</td><td>3.06</td><td>0.080</td><td>6.38</td></tr><tr><td>Positive 3</td><td>80</td><td>7.71</td><td></td><td>0.275</td><td>3.56</td><td>0.680</td><td>8.82</td></tr><tr><td colspan="8">*Outliers detected on Day 12, Run 1, Replicates 1 and 2 **No outliers used in calculation</td></tr><tr><td colspan="8"></td></tr><tr><td>Allergen = nPru p 3, Lot 110, 13325</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1</td><td>84</td><td>0.58</td><td>0.024</td><td></td><td>4.22</td><td>0.039</td><td>6.82</td></tr><tr><td>Positive 2* Positive 2**</td><td>84</td><td>1.97</td><td></td><td>0.063</td><td>3.22</td><td>1.484</td><td>75.41</td></tr><tr><td>Positive 3</td><td>80 84</td><td>1.65 9.19</td><td></td><td>0.060 0.342</td><td>3.63 3.73</td><td>0.111 0.644</td><td>6.75 7.01</td></tr><tr><td colspan="8">Allergen = nPru p 3, Lot 110, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.61</td><td>0.023</td><td></td><td>3.69</td><td>0.032</td><td>5.28</td></tr><tr><td>Positive 2*</td><td></td><td>84 2.08</td><td></td><td>0.104</td><td>4.98</td><td>1.634</td><td>78.56</td></tr><tr><td>Positive 2**</td><td>80</td><td>1.72</td><td></td><td>0.068</td><td>3.91</td><td>0.097</td><td>5.62</td></tr><tr><td>Positive 3</td><td>84</td><td>9.45</td><td>0.291</td><td></td><td>3.07</td><td>0.457</td><td>4.83</td></tr><tr><td colspan="8">Allergen = nPru p 3, Lot 111, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.58</td><td>0.022</td><td>3.70</td><td></td><td>0.037</td><td>6.26</td></tr><tr><td>Positive 2*</td><td>84</td><td>1.99</td><td>0.061</td><td></td><td>3.06</td><td>1.524</td><td>76.70</td></tr><tr><td>Positive 2**</td><td>80</td><td>1.66</td><td>0.048</td><td></td><td>2.87</td><td>0.100</td><td>6.01</td></tr><tr><td>Positive 3</td><td>84</td><td>9.19</td><td></td><td>0.241</td><td>2.62</td><td>0.643</td><td>7.00</td></tr></table>

<table><tr><td colspan="6">Allergen = nPru p 3, Lot 111, 13474</td></tr><tr><td>Positive 1</td><td>84</td><td>0.62</td><td>0.018</td><td>2.92</td><td>0.031 4.95</td></tr><tr><td>Positive 2*</td><td>84</td><td>2.08</td><td>0.130</td><td>6.24 1.613</td><td>77.39</td></tr><tr><td>Positive 2**</td><td>80</td><td>1.73</td><td>0.055 3.18</td><td>0.095</td><td>5.51</td></tr><tr><td>Positive 3</td><td>84</td><td>9.53</td><td>0.269 2.82</td><td>0.434</td><td>4.55</td></tr><tr><td colspan="6">Allergen = nPru p 3, Lot 112, 13325</td></tr><tr><td>Positive 1</td><td>84</td><td>0.56</td><td>0.024 4.32</td><td>0.038</td><td>6.79</td></tr><tr><td>Positive 2*</td><td>84</td><td>1.95</td><td>0.064</td><td>3.28 1.531</td><td>78.70</td></tr><tr><td>Positive 2**</td><td>80</td><td>1.61</td><td>0.57</td><td>3.50 0.109</td><td>6.74</td></tr><tr><td>Positive 3</td><td>84</td><td>9.25</td><td>0.282</td><td>3.05 0.626</td><td>6.77</td></tr><tr><td colspan="6"></td></tr><tr><td>Positive 1</td><td>84</td><td>0.60</td><td>Allergen = nPru p 3, Lot 112, 13474 0.022 3.69</td><td>0.034</td><td>5.71</td></tr><tr><td>Positive 2*</td><td>84</td><td>2.05</td><td>0.152</td><td>7.43 1.654</td><td>80.67</td></tr><tr><td>Positive 2**</td><td>80</td><td>1.69</td><td>0.041</td><td>2.44 0.094</td><td>5.55</td></tr><tr><td>Positive 3</td><td>84</td><td>9.68</td><td>2.98</td><td>3.08 0.461</td><td>4.76</td></tr><tr><td colspan="6">= nPru p 3, Lot 201, 13325</td></tr><tr><td>Positive 1</td><td>80</td><td>Allergen 0.52</td><td>0.022 4.16</td><td>0.037</td><td>7.17</td></tr><tr><td>Positive 2</td><td>80</td><td>1.49</td><td>0.053</td><td>3.56 0.085</td><td>5.70</td></tr><tr><td>Positive 3</td><td>80</td><td>9.05</td><td>0.272</td><td>3.00 0.356</td><td>3.93</td></tr><tr><td colspan="6">Allergen = nPru p 3, Lot 201, 13476</td></tr><tr><td>Positive 1</td><td>80</td><td>0.56</td><td>0.021</td><td>3.73</td><td>0.036 6.49</td></tr><tr><td>Positive 2</td><td>80</td><td>1.57</td><td>0.045</td><td>2.90 0.104</td><td>6.64</td></tr><tr><td>Positive 3</td><td>80</td><td>9.58</td><td>0.289</td><td>3.02 0.486</td><td>5.07</td></tr><tr><td colspan="6">*Outliers detected on Day 10, Runs 1 and 2, Replicates 1 and 2 **No outliers used in calculation</td></tr></table>

Lot-to-Lot variability between four lots on instrument I3325 is presented in the Table 4.

Table 4 - Lot-to-Lot Precision Results   

<table><tr><td colspan="4"></td><td colspan="2">Repeatability</td><td colspan="2">Within-Lab</td></tr><tr><td>Sample</td><td>N</td><td>Mean (KU/L)</td><td>SD (KU/L)</td><td>CV %</td><td>SD (KU/L)</td><td></td><td>CV %</td></tr><tr><td colspan="8">Allergen = rBet v 2, Lots 110, 111, 112, 201, I3325</td></tr><tr><td>Positive 1</td><td>332</td><td>0.57</td><td>0.066</td><td></td><td>11.57</td><td>0.071</td><td>12.57</td></tr><tr><td>Positive 2</td><td></td><td>1.55</td><td></td><td>0.140</td><td>9.06</td><td>0.157</td><td>10.12</td></tr><tr><td>Positive 3</td><td>332 332</td><td>7.85</td><td></td><td>0.773</td><td>9.86</td><td>0.880</td><td>11.22</td></tr><tr><td colspan="8"></td></tr><tr><td>Allergen = rMal d 1, Lots 110, 111, 112, 201, I3325</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive 1</td><td>332</td><td>0.56</td><td>0.067</td><td></td><td>12.01</td><td>0.073</td><td>13.08</td></tr><tr><td>Positive 2</td><td>332</td><td>2.51</td><td></td><td>0.370</td><td>14.76</td><td>0.395</td><td>15.75</td></tr><tr><td>Positive 3</td><td>332</td><td>5.45</td><td>0.657</td><td></td><td>12.06</td><td>0.713</td><td>13.08</td></tr><tr><td colspan="8"></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>Allergen = rMal d 4, Lots 110, 111, 112, 201,.I3325</td><td></td><td></td></tr><tr><td>Positive 1</td><td>332</td><td>0.63</td><td></td><td>0.036</td><td>5.69</td><td>0.041</td><td>6.49</td></tr><tr><td>Positive 2</td><td>332</td><td>1.60</td><td></td><td>0.123</td><td>7.66</td><td>0.143</td><td>8.94</td></tr><tr><td>Positive 3</td><td>332</td><td>7.24</td><td></td><td>0.472</td><td>6.52</td><td>0.596</td><td>8.23</td></tr><tr><td colspan="8"></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>Allergen = rPru av 1, Lots 110, 111, 112, 201, 13325</td><td></td><td></td></tr><tr><td>Positive 1</td><td>332</td><td>0.59</td><td></td><td>0.049</td><td>8.32</td><td>0.055</td><td>9.29</td></tr><tr><td>Positive 2</td><td>332</td><td>2.39</td><td></td><td>0.191</td><td>7.99</td><td>0.327</td><td>13.71</td></tr><tr><td>Positive 3</td><td>332</td><td>6.81</td><td></td><td>0.791</td><td>11.62</td><td>0.853</td><td>12.52</td></tr><tr><td colspan="8">Allergen = rPru av 3, Lots 110, 111, 112, 201, I3325</td></tr><tr><td>Positive 1</td><td></td><td></td><td></td><td></td><td></td><td>0.056</td><td>10.36</td></tr><tr><td>Positive 2</td><td>332</td><td>0.54</td><td>0.053</td><td></td><td>9.75 10.25</td><td>0.158</td><td>11.16</td></tr><tr><td>Positive 3</td><td>332</td><td>1.41</td><td>0.145</td><td></td><td></td><td></td><td>11.61</td></tr><tr><td></td><td>332</td><td>8.91</td><td>0.947</td><td></td><td>10.63</td><td>1.035</td><td></td></tr><tr><td colspan="8">Allergen = rPru av 4, Lots 110, 111, 112, 201, I3325</td></tr><tr><td>Positive 1</td><td></td><td>0.62</td><td></td><td></td><td></td><td>0.036</td><td>5.83</td></tr><tr><td>Positive 2</td><td>332</td><td>1.26</td><td></td><td>0.027</td><td>4.33 8.67</td><td></td><td>15.74</td></tr><tr><td></td><td>334</td><td></td><td></td><td>0.109</td><td></td><td>0.198</td><td></td></tr><tr><td>Positive 3</td><td>332</td><td>8.32</td><td></td><td>0.829</td><td>9.95</td><td>0.928</td><td>11.14</td></tr></table>

<table><tr><td colspan="4">Allergen = nPru p 3, Lots 110, 111, 112, 201, I3325</td></tr><tr><td>Positive 1</td><td>332 0.56</td><td>0.038 6.70 0.045</td><td>7.93</td></tr><tr><td>Positive 2*</td><td>332 1.85</td><td>0.728 39.33 1.351</td><td>72.99</td></tr><tr><td>Positive 2**</td><td></td><td>5.67 0.123</td><td>7.71</td></tr><tr><td>Positive 3</td><td>320 1.60 0.091 332 9.07</td><td>0.469 5.17 0.864</td><td>9.52</td></tr><tr><td colspan="4">*Outliers detected on Day 10, Runs 1 and 2, Replicates 1 and 2 **No outliers used in calculation</td></tr></table>

Precision of rBet v 2, rMal d 1, rMal d 4, rPru av 1, rPru av 3, rPru av 4, and nPru p 3 meet the criteria for acceptable repeatability, within-lab, and lot-to-lot precision. Repeatability is less than $1 5 \%$ for all allergen lots, within-lab precision is less than $1 5 \%$ for all allergen lots, and lot-to-lot precision is less than $2 0 \%$ for all seven allergens. The negative control remained negative $( < 0 . 1 0 \mathrm { k U / L } )$ throughout precision testing on all allergens.

# 8.2 Detection Limits

The working range for the The IMMULITE 2000 3gAllergy Specific IgE Universal Kit is $0 . 1 0 - 1 0 0 \mathrm { k U / L }$ standardized to the $2 ^ { \mathsf { n d } }$ WHO IRP (75/502) for human serum lgE. The Limit of Blank (LoB):

Four blank samples were tested in replicates of two, with one run per day, over five days, using two instruments and three lots of allergen. A total of 80 data points were collected for each allergen lot. The LoB was calculated for each sample using the nonparametric method in accordance with CLSI EP17-A. The Limit of Blank was determined separately for each alergen lot and was established as the highest of the three. The LoB results are presented in Table 5.

Table 5  Limit of Blank Results Summary   

<table><tr><td colspan="1" rowspan="1">Allergen</td><td colspan="1" rowspan="1">Lot</td><td colspan="1" rowspan="1">Limit ofBlank(kU/L)</td></tr><tr><td colspan="1" rowspan="3">rBet v 2(A127)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.03</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.03</td></tr><tr><td colspan="1" rowspan="3">rMal d 1(A464)</td><td colspan="1" rowspan="1">110</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="3">rMal d 4(A796)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.00</td></tr><tr><td colspan="1" rowspan="3">rPru av 1(A597)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.00</td></tr><tr><td colspan="1" rowspan="3">rPru av 3(A599)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.06</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.05</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.01</td></tr><tr><td colspan="1" rowspan="3">rPru av 4(A600)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.01</td></tr><tr><td colspan="1" rowspan="3">nPru p 3(A603)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.02</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.01</td></tr></table>

The Limit of Blank (highest value expected for a sample with no analyte) was ${ \underline { { \leq 0 . 0 3 } } } \mathrm { k U / L }$ for rBet v 2, rMal d 1, rMal d 4, rPru av 1, rPru av 3, and nPru p 3 and $0 . 0 6 \mathrm { \bf k U / L }$ for rPru av 4.

# The Limit of Detection (LoD):

Four low positive samples were tested in replicates of two, with one run per day, over five days, using two instruments and three lots of allergen A total of at least 60 data points were collected for each allergen lot. The LoD was calculated using the formula: $\mathrm { L o D } = \mathrm { L o B } _ { \mathrm { M a x } } + \mathrm { c } _ { \mathrm { p } } \mathrm { S D } _ { \mathrm { L o D } }$ The Limit of Detection was determined separately for each allergen lot and was established as the highest of the three. The LoB results are presented in Table 6.

Table 6 - Limit of Detection Results Summary   

<table><tr><td colspan="1" rowspan="1">Allergen</td><td colspan="1" rowspan="1">Lot</td><td colspan="1" rowspan="1">Limit ofDetection(kU/L)</td></tr><tr><td colspan="1" rowspan="3">rBet v 2(A127)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.05</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.05</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.06</td></tr><tr><td colspan="1" rowspan="3">rMal d 1(A464)</td><td colspan="1" rowspan="1">110</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="3">rMal d 4(A796)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.06</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="3">rPru av I(A597)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.06</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.06</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.05</td></tr><tr><td colspan="1" rowspan="3">rPru av 3(A599)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.09</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.08</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.09</td></tr><tr><td colspan="1" rowspan="3">rPru av 4(A600)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.03</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.05</td></tr><tr><td colspan="1" rowspan="3">nPru p 3(A603)</td><td colspan="1" rowspan="1">111</td><td colspan="1" rowspan="1">0.04</td></tr><tr><td colspan="1" rowspan="1">112</td><td colspan="1" rowspan="1">0.05</td></tr><tr><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">0.04</td></tr></table>

The Limit of Detection (lowest detectable concentration) was ${ \leq } 0 . 1 0 \ k \mathsf { U / L }$ for rBet v 2, rMal d 1, rMal d 4, rPru av 1, rPru av 3, rPru av 4, and nPru ${ \mathfrak { p 3 } }$

# 8.3 Specificity (Inhibition) Studies:

Specificity of each allergen was verified through competitive inhibition testing using a single serum sample or pool of sera. A negative sample was used to measure the background response.

To initiate the inhibition experiment, minimally 5 levels of 5-fold diluted inhibitor extract were mixed with sample or pool at a ratio of l:1 to achieve final inhibitor concentrations of $5 0 ~ \mu \mathrm { g / m L }$ and lower. The inhibitor/sample mixtures were incubated at room temperature $( 1 5 - 2 8 ^ { \circ } \mathrm { C } )$ for 1 hour allowing the immunological reaction to occur. Each sample mixture containing the inhibitor extract and appropriate controls were assayd with one lot of each allergen. The percent $( \% )$ inhibition was calculated according to the following formula:

$[ ( \mathbf { C } - \mathbf { A } ) / \mathbf { C } ] \times 1 0 0$   
E $\mathbf { C } =$ mean response of the positive control (positive sample - negative sample)   
$\mathbf { A } =$ mean response of sample with inhibitor extract

The inhibition demonstrates that the allergens tested are inhibited by the relevant inhibitor extract in a concentration dependent fashion. Also, the target $\%$ inhibition of $50 \%$ for the highest inhibitor concentration tested was met. These results indicate specificity of the rBet v 2, rMal d 1, rMal d 4, rPru av 1, rPru av 3, rPru av 4, and nPru p 3 allergens.

# 8.4 Inhibition Using Negative Controls:

Additional inhibition studies were conducted to show that the specific allergens are not crossreacting to unrelated allergens. Three irrelevant allergens as well as any related components were included as additional controls. The related components were other components of the parent allergen or another component from the same group. The final inhibitor concentrations of the additional inhibitors ranged from $5 0 0 ~ \mu \mathrm { g / m L }$ to $1 2 5 0 ~ \mu \mathrm { g / m L }$ , determined as $1 0 \mathbf { x }$ the concentration needed to achieve ${ \sim } 1 0 0 \%$ inhibition on its own allergen device. Each allergen with the irrelevant and related extracts did not generate inhibition greater than $1 5 \%$ These results indicate specificity of the rBet v 2, rMal d 1, rMal d 4, rPru av 1, rPru av 3, rPru av 4, and nPru p 3 allergens.

# 8.5 Linearity:

The assay is calibrated to the WHO 2nd IRP 75/502 reference standard for total $\mathrm { I g E }$ The working range is supported in the following manner: Each allergen was scaled to confirm linearity. The calibration curve for the assay is utilized for reporting lgE dose values for all allergens assayed. To confirm the working range of 0.10 to $1 0 0 ~ { \ k } \mathrm { U / L }$ , a linearity study was performed with the calibrator antibody using a minimum of 3 samples scaled throughout the reportable range of the assay.

Two positive samples were diluted with a negative sample at levels ranging from $20 \%$ to $100 \%$ EY per CLSI EP06-A. The negative sample was run neat as a control. Each sample was run in replicates of three with two allergen lots. The expected dose (kU/L) was extrapolated from the neat positive value and the linearity.dilutions. A linear regression was performed by plotting the observed dose (y-axis) versus the expected dose ( $\mathbf { \dot { x } }$ -axis) as shown in Table 7.

Table 7: Linearity Table   

<table><tr><td rowspan=1 colspan=1>Allergen</td><td rowspan=1 colspan=1>Lot</td><td rowspan=1 colspan=1>RegressionEquation</td><td rowspan=1 colspan=1>r</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Slope 95% CI</td><td rowspan=1 colspan=1>Intercept 95% CI</td><td rowspan=1 colspan=1>Range Tested (kU/L)</td></tr><tr><td rowspan=2 colspan=1>rBet v 2</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y = 1.003x + 0.006</td><td rowspan=1 colspan=1>0.998</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.953 to 1.053</td><td rowspan=1 colspan=1>-0.050 to 0.061</td><td rowspan=1 colspan=1>0.46 to 13.08</td></tr><tr><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y = 1.035x + 0.006</td><td rowspan=1 colspan=1>0.998</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.987 to 1.083</td><td rowspan=1 colspan=1>-0.043 to 0.056</td><td rowspan=1 colspan=1>0.43 to 12.81</td></tr><tr><td rowspan=2 colspan=1>rMal d 1</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>y = 1.012x + 0.091</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.986 to 1.039</td><td rowspan=1 colspan=1>0.002 to 0.180</td><td rowspan=1 colspan=1>1.48 to 24.74</td></tr><tr><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y = 1.036 -0.075</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>1.001 to 1.070</td><td rowspan=1 colspan=1>-0.199 to 0.049</td><td rowspan=1 colspan=1>1.42 to 26.33</td></tr><tr><td rowspan=2 colspan=1>rMal d 4</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y = 0.958 + 0.042</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.921 to 0.995</td><td rowspan=1 colspan=1>0.011 to 0.074</td><td rowspan=1 colspan=1>0.35 to 11.55</td></tr><tr><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y = 0.984x + 0.018</td><td rowspan=1 colspan=1>0.998</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.936 to 1.032</td><td rowspan=1 colspan=1>-0.022 to 0.058</td><td rowspan=1 colspan=1>0.32 to 11.58</td></tr><tr><td rowspan=2 colspan=1>rPru av 1</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y =1.047x- 0.030</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>1.013 to 1.081</td><td rowspan=1 colspan=1>-0.053 to -0.007</td><td rowspan=1 colspan=1>0.24 to 14.08</td></tr><tr><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y = 1.054x + 0.020</td><td rowspan=1 colspan=1>0.998</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.999 to 1.110</td><td rowspan=1 colspan=1>-0.014 to 0.055</td><td rowspan=1 colspan=1>0.25 to 18.52</td></tr><tr><td rowspan=2 colspan=1>rPru av 3</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y = 1.004x +0.048</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.978 to 1,031</td><td rowspan=1 colspan=1>0.023 to 0.074</td><td rowspan=1 colspan=1>0.43 to 13.55</td></tr><tr><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y = 0.992x + 0.058</td><td rowspan=1 colspan=1>0,999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.961 to 1.023</td><td rowspan=1 colspan=1>0.028 to 0.088</td><td rowspan=1 colspan=1>0.44 to 13.36</td></tr><tr><td rowspan=2 colspan=1>rPru av 4</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y = 0.967 + 0.018</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.945 to 0.989</td><td rowspan=1 colspan=1>-0.003 to 0.040</td><td rowspan=1 colspan=1>0.38 to 19.95</td></tr><tr><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y = 0.984x + 0.034</td><td rowspan=1 colspan=1>1,000</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.960 to 1.009</td><td rowspan=1 colspan=1>0.010 to 0.058</td><td rowspan=1 colspan=1>0.41 to 19.35</td></tr><tr><td rowspan=2 colspan=1>nPru p 3</td><td rowspan=1 colspan=1>111</td><td rowspan=1 colspan=1>y = 0.989x + 0.049</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.960 to 1.019</td><td rowspan=1 colspan=1>0.018 to 0.081</td><td rowspan=1 colspan=1>0.47 to 15.62</td></tr><tr><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y =1.000x + 0.022</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0.966 to 1.034</td><td rowspan=1 colspan=1>-0.014 to 0.057</td><td rowspan=1 colspan=1>0.43 to 15.29</td></tr></table>

# 9Clinical Performance Testing:

Clinical performance was demonstrated by testing serum samples against specific allergens from clinically diagnosed atopic and non-atopic individuals. Allergen-specific testing was obtained using the IMMULITE® 2000 3gAllergyTM Specific IgE Universal Kit.

Data summary agreement of the IMMUL $\Gamma \Gamma \overline { { \mathrm { E } } } ^ { \mathfrak { B } }$ 2000 3gAllergy™ Specific IgE Universal Kit test results to clinical data is shown in Table 8.

Table 8: Clinical Data Summary   

<table><tr><td rowspan=1 colspan=4>Clinical Diagnosis Data</td></tr><tr><td rowspan=1 colspan=1>IMMULITE® 2000 Analyzer</td><td rowspan=1 colspan=1>Clinical</td><td rowspan=1 colspan=1>Normal</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>153</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>162</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>174</td><td rowspan=1 colspan=1>810</td><td rowspan=1 colspan=1>984</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>327</td><td rowspan=1 colspan=1>819</td><td rowspan=1 colspan=1>1,146</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td rowspan=2 colspan=1></td><td rowspan=1 colspan=1>46.8%</td><td rowspan=1 colspan=1>98.9%</td><td rowspan=1 colspan=1>84.0%</td></tr><tr><td rowspan=1 colspan=1>Sensitivity</td><td rowspan=1 colspan=1>Specificity</td><td rowspan=1 colspan=1>Agreement</td></tr><tr><td rowspan=1 colspan=1>Lower Confidence Interval</td><td rowspan=1 colspan=1>42.1%</td><td rowspan=1 colspan=1>98.1%</td><td rowspan=1 colspan=1>82%</td></tr><tr><td rowspan=1 colspan=1>Upper Confidence Interval</td><td rowspan=1 colspan=1>51.5%</td><td rowspan=1 colspan=1>99.4%</td><td rowspan=1 colspan=1>86%</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=4>Allergens included: rBet v 2, rMal d 1, rPru av 1, rPru av 3, rPru av 4, nPru p 3 and rMal d 4</td></tr></table>

MMULITE® 2000 3gAllergy™ Specific IgE Universal Kit test results for all allergens compare well with clinical documentation of presence or absence of signs, symptoms and other diagnostic evidence of allergen sensitivity

# 10. Conclusion:

The IMMULITE $\textsuperscript { \textregistered }$ 2000 3gAllergyTM Specific IgE Universal Kit is substantially equivalent to other products in commercial distribution intended for similar use. Most notably, it is substantially equivalent to the currently marketed device. The substantial equivalence of the device is supported by clinical and non-clinical testing and was found to be comparable and supports the claims of substantial equivalence, product safety and effectiveness. Based on the testing completed and the comparisons with predicate device, the IMMULITE $\otimes$ 2000 3gAllergyTM Specific IgE Universal Kit does not raise any new questions on safety and effectiveness and the results support a determination of substantial equivalence.

# SIEMENS HEALTHCARE DIAGNOSTICS, INC. May 28, 2014 C/O MR. ERNEST JOSEPH SENIOR MANAGER REGULATORY AFFAIRS IMMULITE AND RIA PRODUCT LINES 511 BENEDICT AVENUE TARRYTOWN, NY, 10591

Re: K132801 Trade/Device Name: IMMULITE 2000 3gAlleryTM Specific IgE Universal Kit Regulation Number: 21 CFR $\ S$ 866.5750 Regulation Name: Radioallergosorbent (RAST) immunological test system Regulatory Class: Class II Product Code: DHB Dated: May 2, 2014 Received: May 5, 2014

Dear Mr. Joseph:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with al the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

device-related adverse cvents) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http:/www.fda.gov/McdicalDevices/ResourcesforYou/lndustry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRHl's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-204 1 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Maria M. Chan -S

Maria M. Chan, Ph.D.   
Director   
Division of lmmunology and Hematology Devices Office of In Vitro Diagnostics   
and Radiological Health (OIR)   
Center for Devices and Radiological Health

510(k) Number (if known) K132801

Device Name IMMULITE@ 2000 3gAllergy™ Specific IgE Universal Kit

Indications for Use (Descrbe) The 3gAllergySpeciic Univesal Kit s  in vito diagnosticuse with he MULTE 00Analyzer —r he alioeTheteul  nn w cnlni nh a.

# FOR FDA USE ONLY

Elizabeth A. Stafford -S

This section applies only to requirements of the Paperwork Reduction Act of 1995.

'Do NOT SEND YOUR CoMPLEtED fORM TO tHE PRA StAFF EmAil aDDRESS BELOW.'

The burden tme for his collection of information is estmated toverage79hours per response, includng the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the colection of information. Send comments regarding this burden estimate or any other aspect of this inforrmation collection, induding suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."